Protein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins

Molecular and Cellular Biology

Volumn 22, Issue 7, 2002, Pages 2136-2146

  Han, Innoc ^a   Xue, Yong ^a   Harada, Shizuko ^a   Orstavik, Sigurd ^a   Skalhegg, Bjorn ^a   Kieff, Elliott ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; PROTEIN HA95; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; B CELL LYMPHOMA; CONFOCAL MICROSCOPY; EPSTEIN BARR VIRUS; GENE TRANSFER; GENETIC TRANSFECTION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LYMPHOBLASTOID CELL; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; TRANSCRIPTION REGULATION; TWO HYBRID SYSTEM;

CARRIER PROTEINS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, GENETIC; NUCLEAR PROTEINS; OPEN READING FRAMES; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; REPETITIVE SEQUENCES, AMINO ACID; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UP-REGULATION; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0036124591     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.7.2136-2146.2002     Document Type: Article

References (78)

1. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein
2. Early events in Epstein-Barr virus infection of human B lymphocytes
3. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A
4. Characterisation of regulatory sequences at the Epstein-Barr virus BamH1 W promoter
5. An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator
6. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation
7. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
8. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23
9. The EVES motif mediates both intermolecular and intramolecular regulation of c-Myc
10. Protein kinase A anchoring
11. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study
12. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: Role in NF-κB activation
13. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit
14. Molecular cloning, chromosomal localization, and cell cycle-dependent subcellular distribution of the A-kinase anchoring protein, AKAP95
15. Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha
16. Virus particles in cultured lymphoblasts from Burkitt's lymphoma
17. Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element
18. Response to cAMP levels of the Epstein-Barr virus EBNA2-inducible LMP1 oncogene and EBNA2 inhibition of a PP1-like activity
19. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines
20. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein
21. Recombinant fragment of protein kinase inhibitor blocks cyclic AMP-dependent gene transcription
22. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes
23. EBNA-LP associates with cellular proteins including DNA-PK and HA95
24. Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation
25. Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-association
26. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa
27. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma
28. Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells
29. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells
30. Decreased catalytic subunit mRNA levels and altered catalytic subunit mRNA structure in a cAMP-resistant Chinese hamster ovary cell line
31. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1
32. The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2
33. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation
34. Epstein-Barr virus and its replication
35. The activity of the Epstein-Barr virus BamHI W promoter in B cells is dependent on the binding of CREB/ATF factors
36. Cell cycle stage-specific phosphorylation of the Epstein-Barr virus immortalization protein EBNA-LP
37. Pim-1 kinase and p100 cooperate to enhance c-Myb activity
38. A role for RNA helicase A in post-transcriptional regulation of HIV type 1
39. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1
40. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif
41. Posttranslational processing of the Epstein-Barr virus-encoded p63/LMP protein
42. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation
43. HA95 is a protein of the chromatin and nuclear matrix regulating nuclear envelope dynamics
44. Both isoforms of the cAMP-dependent protein kinase catalytic subunit can activate transcription of the prolactin gene
45. Transcriptional regulation by cyclic AMP
46. RNA helicase A mediates association of CBP with RNA polymerase II
47. Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: A role for the W1W2 repeat domain
48. Identification, cloning and characterization of a novel nuclear protein, HA95, homologous to A-kinase anchoring protein 95
49. Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2
50. Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins
51. Establishment of cell lines from peripheral leukocytes in infectious mononucleosis
52. Transformation of huiman foetal leukocytes in vitro by filtrates of a human leukaemic line containing Herpes-like virus
53. Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs
54. Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: A probable transcriptional initiation site
55. Developments in expression cloning
56. EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus
57. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter
58. An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter
59. EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus
60. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies
61. An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA
62. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes
63. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation
64. The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2
65. The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE
66. The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein
67. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression
68. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23
69. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23
70. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element
71. A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes
72. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter
73. The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest
74. A novel shuttle protein binds to RNA helicase A and activates the retroviral constitutive transport element
75. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV
76. Mapping the functional domains of HAP95, a protein that binds RNA helicase A and activates the constitutive transport element of type D retroviruses
77. Identification of major phosphorylation sites of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP): Ability of EBNA-LP to induce latent membrane protein 1 cooperatively with EBNA-2 is regulated by phosphorylation